IP Library Granted Patent US 6,894,170
Granted Patent B2
US 6,894,170 · App. 10/270,324 · Granted May 17, 2005

Process for the preparation of substituted thiazolines and their intermediates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,894,170
App. No.
10/270,324
Granted
May 17, 2005
Kind
B2
Abstract

Process for the preparation of substituted thiazolines of the formula (I) in which Ar is a phenyl, naphthyl, thienyl, pyridyl or quinolinyl radical which can optionally be substituted by one or more substituents from the group consisting of halogen, OH, benzyloxy, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, COOR 1 where R 1 is H or C 1 -C 4 -alkyl, by coupling of (S)-α-methylcysteine hydrochloride of the formula (II) with a nitrile of the formula (III) Ar—CN in which Ar is as defined above, or a corresponding C 1 -C 4 -alkyl imidate, in which (S)-α-methylcysteine hydrochloride of the formula (II) is reacted in a suitable solvent with a nitrile of the formula (III) or a corresponding C 1 -C 4 -alkyl imidate in the presence of a tertiary base at a pH of 6.5 to 10 at 50° C. up to the reflux temperature to give the corresponding thiazoline of the formula (I), and processes for the preparation of (S)-α-methylcysteine hydrochloride and its use for the preparation of thiazolines of the formula (I).

Claims (13)

1. A process for the preparation of substituted thiazolines of the formula (I)

in which Ar is a phenyl, naphthyl, thienyl, pyridyl or quinolinyl radical which can optionally be substituted by one or more substituents from the group consisting of halogen, OH, benzyloxy, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, COOR 1 where R 1 is H or C 1 -C 4 -alkyl,

by coupling of (S)-α-methylcysteine hydrochloride of the formula (II)

with an aromatic or heteroaromatic nitrile of the formula (III)

Ar—CN

in which Ar is as defined above, or a corresponding C 1 -C 4 -alkyl imidate, which comprises reacting (S)-α-methylcysteine hydrochloride of the formula (II) in ethanol and/or butanol as solvent, containing 0.5 to 2 mol of a nitrile of the formula (III) or a corresponding C 1 -C 4 -alkyl imidate per mole of (S)-α-methylcysteine hydrochloride in the presence of 1.5 to 3 mol of a tertiary base per mole of (S)-α-methylcysteine hydrochloride at a pH of 6.5 to 10 at 50° C. up to the reflux temperature to give the corresponding thiazoline of the formula (I), which is isolated from the reaction mixture by removal of the solvent, extraction of the impurities and precipitation of the thiazoline by acidification.

2. The process as claimed in claim 1 , wherein substituted thiazolines of the formula (I) are prepared in which Ar is a phenyl or naphthyl radical which can optionally be substituted by one or two substituents from the group consisting of OH, methyl, methoxy and COOH.

3. A process for the preparation of substituted thiazolines of the formula (I)

in which Ar is a phenyl or naphthyl radical which can optionally be substituted by one or two substituents from the group consisting of OH, methyl, methoxy and COOH,

by coupling of (S)-α-methylcysteine hydrochloride of the formula (II)

with an aromatic or heteroaromatic nitrile of the formula (III)

Ar—CN

in which Ar is as defined above, or a corresponding C 1 -C 4 -alkyl imidate, which comprises reacting (S)-α-methylcysteine hydrochloride of the formula (II) in ethanol and/or butanol as solvent, containing 0.5 to 2 mol of a nitrile of the formula (III) or a corresponding C 1 -C4-alkyl imidate per mole of (S)-α-methylcysteine hydrochloride in the presence of 1.5 to 3 mol of a tertiary base per mole of (S)-α-methylcysteine hydrochloride at a pH of 6.5 to 10 at 50° C. up to the reflux temperature to give the corresponding thiazoline of the formula (I), which is isolated from the reaction mixture by removal of the solvent, extraction of the impurities and precipitation of the thiazoline by acidification.

Assignments (3)
RELEASE (REEL 032424 / FRAME 0001) Recorded Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG
Reel/Frame 044037/0879 →
NOTICE OF SUCCESSION OF AGENCY FOR PATENT SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (032424/0001) Recorded Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043165/0987 →
SECURITY INTEREST Recorded Mar 11, 2014
From: DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032424/0001 →